Miltefosine for Indian visceral leishmaniasis.
Agarwal
Pradeep K
PK
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications / Q000188:drug therapy*; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013154:Spleen / Q000473:pathology; D013396:Suction / Q000009:adverse effects; D013921:Thrombocytopenia / Q000150:complications
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine